Key statistics
On Friday, Pacira Biosciences Inc (PCRX:NSQ) closed at 21.91, 16.54% above the 52 week low of 18.80 set on Jan 20, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 21.14 |
|---|---|
| High | 22.41 |
| Low | 20.62 |
| Bid | 21.01 |
| Offer | 23.31 |
| Previous close | 22.59 |
| Average volume | 952.92k |
|---|---|
| Shares outstanding | 40.49m |
| Free float | 39.89m |
| P/E (TTM) | 139.48 |
| Market cap | 887.13m USD |
| EPS (TTM) | 0.1571 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
- Pacira to Report 2025 Financial Results on Thursday February 26, 2026
- Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
